Surgical Treatment of Superior Sulcus Tumors
Kiyoshi Koizumi(Nippon Medical School), Kazuo Shimizu(Nippon Medical School), Daisuke Okada(Saiseikai Kumamoto Hospital), Iwao Mikami(Hokkaido University Hospital), Hiroyasu Kinoshita(Nippon Medical School), Yuki Nakajima(Fujisawa City Hospital), Shigeki Yamagishi(Nippon Medical School), Shuji Haraguchi(Nippon Medical School), Kyoji Hirai(Nippon Medical School), Tomomi Hirata(Nippon Medical School), Yutaka Enomoto(Mitsui Memorial Hospital)
Cited by 6
Related Papers
First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
|Journal of Clinical Oncology|2009|516
Nucleosides and nucleotides. 100. 2'-C-Cyano-2'-deoxy-1-.beta.-D-arabinofuranosylcytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside
|Journal of Medicinal Chemistry|1991|85
Japanese Clinical Practice Guidelines for Rehabilitation in Critically Ill Patients 2023 (J-ReCIP 2023)
|Journal of Intensive Care|2023|60
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era
|European Journal Of Haematology|2013|58